-
Mashup Score: 8Updates in Thrombosis Management:The Emerging Role of Factor XI Inhibition | LinkedIn - 3 day(s) ago
See who else is going to Updates in Thrombosis Management:The Emerging Role of Factor XI Inhibition, and keep up-to-date with conversations about the
Source: www.linkedin.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 8Updates in Thrombosis Management:The Emerging Role of Factor XI Inhibition | LinkedIn - 5 day(s) ago
See who else is going to Updates in Thrombosis Management:The Emerging Role of Factor XI Inhibition, and keep up-to-date with conversations about the
Source: www.linkedin.comCategories: General Medicine News, Cardiology News and JournTweet-
❓ What’s next in thrombosis management? Join @GBarnesMD and @manesh_patelMD in this LIVE social media event as they discuss the gaps in thrombosis management and share their thoughts on the emerging role of factor XI inhibition. Register your interest ➡️ https://t.co/a6JObufehq https://t.co/FhTQGvEjjJ
-
-
Mashup Score: 4Heart of Cardio - 17 day(s) ago
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from Heart Failure, Atherosclerosis and Thrombosis to Cardiometabolic Disease, Arrythmia Management and Valvular Heart Disease, on top of other urgent issues for practitioners. This 3-day meeting provides interactive presentations, Q & As, panel discussions and networking opportunities. In addition to the scientific sessions, there will be informative Bonus Presentat
Source: www.heartofcardio.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 4Heart of Cardio - 18 day(s) ago
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from Heart Failure, Atherosclerosis and Thrombosis to Cardiometabolic Disease, Arrythmia Management and Valvular Heart Disease, on top of other urgent issues for practitioners. This 3-day meeting provides interactive presentations, Q & As, panel discussions and networking opportunities. In addition to the scientific sessions, there will be informative Bonus Presentat
Source: www.heartofcardio.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0ACC Conference Wrap-up: Thromboembolic Disease and Antithrombotic Therapy Highlights - 1 month(s) ago
Join us as our faculty review highlights from the conference and discuss optimal management of thromboembolic disease in 2024.
Source: www.medscape.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 3ACC Conference Wrap-up: Thromboembolic Disease Highlights - 1 month(s) ago
Join us for a symposium on thromboembolic disease designed to encourage the exchange of ideas between leaders in the field and attendees. Click the ‘Notify M…
Source: www.youtube.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 4ACC Conference Wrap-up: Thromboembolic Disease Highlights - 1 month(s) ago
Join us for a symposium on thromboembolic disease designed to encourage the exchange of ideas between leaders in the field and attendees. Click the ‘Notify M…
Source: www.youtube.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 3ACC Conference Wrap-up: Thromboembolic Disease Highlights - 1 month(s) ago
Join us for a symposium on thromboembolic disease designed to encourage the exchange of ideas between leaders in the field and attendees. Click the ‘Notify M…
Source: www.youtube.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 2Home - 1 month(s) ago
Anticoagulant use has been critical for reducing the risk of stroke in patients with atrial fibrillation. However, currently available agents are often underutilized or utilized inappropriately primarily due to safety concerns, leading to suboptimal patient outcomes. Emerging evidence suggests that factor XI is a promising new target for inhibition of pathological thrombosis. Join us in this gameshow format and test your knowledge against your peers about thromboembolic disease and factor XI inhibition!
Source: events.medscapelive.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 2Home - 1 month(s) ago
Anticoagulant use has been critical for reducing the risk of stroke in patients with atrial fibrillation. However, currently available agents are often underutilized or utilized inappropriately primarily due to safety concerns, leading to suboptimal patient outcomes. Emerging evidence suggests that factor XI is a promising new target for inhibition of pathological thrombosis. Join us in this gameshow format and test your knowledge against your peers about thromboembolic disease and factor XI inhibition!
Source: events.medscapelive.orgCategories: General Medicine News, Cardiology News and JournTweet
❓ What’s next in thrombosis management? Join @GBarnesMD and @manesh_patelMD in this LIVE social media event as they discuss the gaps in thrombosis management and share their thoughts on the emerging role of factor XI inhibition. Register your interest ➡️ https://t.co/a6JObufehq https://t.co/FhTQGvEjjJ